Jiangsu Hengrui Pharmaceuticals Co.,Ltd Company Information
Jiangsu Hengrui Pharmaceuticals Co.,Ltd's employee growth, exchange listings and data sources
Key Information
- Name: Jiangsu Hengrui Pharmaceuticals Co.,Ltd
- Ticker: 600276
- Exchange: SHSE
- Founded: 1970
- Industry: Pharmaceuticals
- Sector: Pharmaceuticals & Biotech
- Market Cap: CN¥412.355b
- Shares Outstanding: 6.62b
- Website: https://www.hengrui.com
Number of Employees
Location
- Jiangsu Hengrui Pharmaceuticals Co.,Ltd
- No. 38, Huanghe Road
- Economic and Technological Development Zone
- Lianyungang
- Jiangsu Province
- 222047
- China
Listings
| Ticker | Exchange | Primary Security | Security Type | Country | Currency | Listed on |
|---|---|---|---|---|---|---|
| 600276 | SHSE (Shanghai Stock Exchange) | Yes | Domestic Shares | CN | CNY | Oct 2000 |
| 600276 | XSSC (Shanghai Stock Exchange - Shanghai - Hong Kong Stock Connect) | Yes | Domestic Shares | CN | CNY | Oct 2000 |
| 0BO | DUSE (Dusseldorf Stock Exchange) | H Shares | DE | EUR | May 2025 | |
| 1276 | SEHK (The Stock Exchange of Hong Kong Ltd.) | H Shares | HK | HKD | May 2025 | |
| 0BO | DB (Deutsche Boerse AG) | H Shares | DE | EUR | May 2025 | |
| 1276 | SZSC (The Stock Exchange of Hong Kong - Shenzhen - Hong Kong Stock Connect) | H Shares | HK | HKD | May 2025 | |
| 1276 | SHSC (Stock Exchange of Hong Kong Limited - Shanghai - Hong Kong Stock Connect) | H Shares | HK | HKD | May 2025 |
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/11/12 23:23 |
| End of Day Share Price | 2025/11/12 00:00 |
| Earnings | 2025/09/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Jiangsu Hengrui Pharmaceuticals Co.,Ltd is covered by 46 analysts. 25 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Bo Li | BofA Global Research |
| Yanan Hou | Bohai Securities Co., Ltd. |
| Shun Kei Law | CCB International Securities Limited |